Health News

Transition Therapeutics Announces Fiscal 2013 Year End Financial Results

Author: Australian Business

TORONTO, Sept. 11, 2013 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets, today announced its financial results for the......

More...

More Articles...

MediFocus: Future of Molecular Imaging
2014 Opportunities in the US Blood Banking Market
Physicians' Lobby Kills Bill To Suspend Privileges of Doctors Whose Prescribing Led To Overdose Deaths, says Consumer Watchdog
Medical Polymers, Resins And Fibers (PVC, PP, PE, PS), Elastomers (SBC, Rubber Latex), Biodegradable Plastics Market For Devices, Equipment, Packaging And Other Applications - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2012 -
Rogers to Serve as Host for Innovative and Much-Needed Pediatric OCD Training for Mental Health Professionals
Intrepid Fallen Heroes Fund Dedicates New $11-Million Center To Treat Traumatic Brain Injury (TBI) And Post Traumatic Stress (PTS) In America's Wounded Military Service Members
Case Report Suggests Microbiome Therapeutics' NM504 May Improve Tolerability of Metformin While Improving Blood Glucose Control
Polyether Ether Ketone (PEEK) Market worth $831 Million by 2018
Accel-KKR Makes a Majority Investment in EA Holdings, Inc. to Accelerate Company's Growth
WebMD Health Corp. Announces Preliminary Results of Its Tender Offer

Page 1819 of 1908